Multiple financial institutions, including Goldman Sachs, Morgan Stanley, Bank of America, UBS, and others, provided ratings and price targets for Marvell Technology on May 28, 2026.
Steady: 0 in the last 7 days
Updated nov 6
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Multiple financial institutions, including Goldman Sachs, Morgan Stanley, Bank of America, UBS, and others, provided ratings and price targets for Marvell Technology on May 28, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley boosted Marvell's price target while Bank of America downgraded the stock.1 source
- Goldman Sachs raised its outlook for data center growth, following general coverage of Marvell Technology's stock.Sub-event
Ratings firms maintain bullish outlook on Marvell; Google reportedly interested in buying shares.1 source
UBS and Goldman Sachs updated ratings for Marvell Technology, coinciding with CEO insider selling activity.1 source
- JPMorgan Chase, Morgan Stanley, UBS, and Bank of America raised price targets for a company, signaling confidence in its future prospects.Sub-event
- Financial institutions, including UBS and Deutsche Bank, upgraded Elevance Health to Buy rating on May 28, 2026, while it operates as a health insurer in the United States.Sub-event
Ratings and price targets issued by major banks (GS, MS, BofA, UBS) for Marvell Technology on May 28.1 source
Keep exploring
The entities involved
-
Marvell Technology
American fabless semiconductor company
-
Goldman Sachs
American investment bank
- Goldman Sachs reinforces concerns about the AI bubble, while Sam Altman (CEO of OpenAI) notes that a rate cut by the Fed is welcome news for tech players.
- Renaissance Technologies bought large stakes in Goldman Sachs, Morgan Stanley, and Bank of America and added positions in Citigroup and JPMorgan Chase.
-
Morgan Stanley
U.S. investment bank
-
Bank of America
American multinational banking and financial services corporation
Related events
- Sylvamo received rating updates from Bank of America, Truist Financial, and RBC on July 19, reiterating neutral ratings and lowering price targets.
- Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.
- Morgan Stanley lifted its price target and gave an overweight rating for Hewlett Packard Enterprise, while Susquehanna reduced its target and set a neutral rating.
- Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.